DNAlite Therapeutics fetches $1.5 mln


DNAlite Therapeutics Inc, an gastrointestinal gene therapy biotech startup, has raised $1.5 million in seed financing. Berkeley Catalyst Fund led the round with participation from University of California Berkeley, Blue Bear Ventures, SOSV, the Baldota family, BrightGene and SVE Capital.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.